T-cell prolymphocytic leukemia classification: Difference between revisions
No edit summary |
No edit summary |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{T-cell prolymphocytic leukemia}} | |||
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | |||
==Overview== | |||
[[T cell|T-cell]] [[prolymphocytic leukemia]] is classified into three variants based on its [[morphology]]. | |||
==Classification== | |||
[[T cell|T-cell]] [[prolymphocytic leukemia]] [[classification]] is based on its [[morphology]]. <ref name="pmid23382603">{{cite journal |vauthors=Graham RL, Cooper B, Krause JR |title=T-cell prolymphocytic leukemia |journal=Proc (Bayl Univ Med Cent) |volume=26 |issue=1 |pages=19–21 |year=2013 |pmid=23382603 |pmc=3523759 |doi= |url=}}</ref><ref name="pmid26980727">{{cite journal |vauthors=Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES |title=The 2016 revision of the World Health Organization classification of lymphoid neoplasms |journal=Blood |volume=127 |issue=20 |pages=2375–90 |date=May 2016 |pmid=26980727 |pmc=4874220 |doi=10.1182/blood-2016-01-643569 |url=}}</ref><ref name="pmid1742486">{{cite journal |vauthors=Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D |title=Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia |journal=Blood |volume=78 |issue=12 |pages=3269–74 |date=December 1991 |pmid=1742486 |doi= |url=}}</ref><ref name="pmid17369126">{{cite journal |vauthors=Foucar K |title=Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome |journal=Am. J. Clin. Pathol. |volume=127 |issue=4 |pages=496–510 |date=April 2007 |pmid=17369126 |doi=10.1309/KWJYBCCGTB90B6AE |url=}}</ref> | |||
* | |||
{| align="center" | |||
! rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Morphological Variant | |||
! rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Percentage of total number | |||
|- | |||
! colspan="1" align="center" style="background:#DCDCDC;" |Typical T-cell prolymphocytic leukemia | |||
! colspan="1" align="center" style="background:#DCDCDC;" |75 percent | |||
|- | |||
! colspan="1" align="center" style="background:#DCDCDC;" |Small cell variant | |||
! colspan="1" align="center" style="background:#DCDCDC;" |20 percent | |||
|- | |||
! colspan="1" align="center" style="background:#DCDCDC;" |Cerebriform (Sézary cell-like) variant | |||
! colspan="1" align="center" style="background:#DCDCDC;" |5 percent | |||
|} | |||
{{T-cell-prolymphocytic leukemia}} | {{T-cell-prolymphocytic leukemia}} | ||
Latest revision as of 15:27, 3 April 2019
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia classification On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia classification |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]
Overview
T-cell prolymphocytic leukemia is classified into three variants based on its morphology.
Classification
T-cell prolymphocytic leukemia classification is based on its morphology. [1][2][3][4]
| Morphological Variant | Percentage of total number |
|---|---|
| Typical T-cell prolymphocytic leukemia | 75 percent |
| Small cell variant | 20 percent |
| Cerebriform (Sézary cell-like) variant | 5 percent |
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell Prolymphocytic Leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia classification On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia classification |
|
Directions to Hospitals Treating T-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia classification |
References
- ↑ Graham RL, Cooper B, Krause JR (2013). "T-cell prolymphocytic leukemia". Proc (Bayl Univ Med Cent). 26 (1): 19–21. PMC 3523759. PMID 23382603.
- ↑ Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (May 2016). "The 2016 revision of the World Health Organization classification of lymphoid neoplasms". Blood. 127 (20): 2375–90. doi:10.1182/blood-2016-01-643569. PMC 4874220. PMID 26980727.
- ↑ Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D (December 1991). "Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia". Blood. 78 (12): 3269–74. PMID 1742486.
- ↑ Foucar K (April 2007). "Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome". Am. J. Clin. Pathol. 127 (4): 496–510. doi:10.1309/KWJYBCCGTB90B6AE. PMID 17369126.